Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.
about
Targeted delivery of amikacin into granuloma.Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophagesEfficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected miceGamma interferon is essential for clearing Mycobacterium genavense infection.Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infectionNanotechnology-Based Approach in Tuberculosis Treatment.Amikacin: Uses, Resistance, and Prospects for Inhibition.
P2860
Q33652356-6203A813-CE31-4744-B4D3-6EBB60074E83Q33699804-64647D86-BA36-45FB-8B53-85D4ED439978Q33976250-6ACFB43F-169D-4BC0-8BE3-EB953E8B724EQ34004863-82E53398-2A90-43E8-9A92-147783A77936Q34110906-6682E0B3-A706-4B9B-9DEE-748E623F8DBCQ37624974-6C0890F6-5C76-4BD9-BBDF-3EA2438AFE80Q52744431-28D5CEF2-0491-42F3-838E-0AA00784DB0F
P2860
Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Rationale for and efficacy of ...... Mycobacterium avium infection.
@ast
Rationale for and efficacy of ...... Mycobacterium avium infection.
@en
type
label
Rationale for and efficacy of ...... Mycobacterium avium infection.
@ast
Rationale for and efficacy of ...... Mycobacterium avium infection.
@en
prefLabel
Rationale for and efficacy of ...... Mycobacterium avium infection.
@ast
Rationale for and efficacy of ...... Mycobacterium avium infection.
@en
P2093
P2860
P1476
Rationale for and efficacy of ...... Mycobacterium avium infection.
@en
P2093
P2860
P304
P407
P577
1998-02-01T00:00:00Z